title: Mucocutaneous features of autoimmune blistering diseases.
abstract: This review will describe adult onset mucocutaneous/autoimmune diseases that involve defects in cell-to-cell, cell-to-matrix, or cell-to-basement membrane adhesion. Included in this group are pemphigus, cicatricial pemphigoid, linear IgA bullous dermatosis, epidermolysis bullosa acquisita, and bullous systemic lupus erythematous. Detection and treatment of blistering disorders that manifest early in the oral cavity may prevent widespread involvement of skin. During the past few years, targets of autoantibodies have been clarified and new targets have been identified, allowing better understanding of the pathophysiology involved in these diseases. New information about more effective regimens with fewer side effects has also been obtained, presenting new treatment options. Clinical manifestations and management of these disorders will be described as well as histopathologic, ultrastructural, and immunopathologic studies that distinguish each disorder and facilitate diagnosis and treatment.
authors.affiliation: Department of Periodontics, New York University College of Dentistry, NY 10010, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Weinberg
authors.forename: M S
authors.initials: MS
authors.lastname: Insler
authors.forename: R B
authors.initials: RB
authors.lastname: Campen
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000473:pathology* / Q000628:therapy; D001485:Basement Membrane / Q000276:immunology / Q000473:pathology; D002448:Cell Adhesion; D016107:Epidermolysis Bullosa Acquisita / Q000276:immunology / Q000473:pathology / Q000628:therapy; D005109:Extracellular Matrix / Q000276:immunology / Q000473:pathology; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000473:pathology / Q000628:therapy; D009059:Mouth Diseases / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D010390:Pemphigoid, Benign Mucous Membrane / Q000276:immunology / Q000473:pathology / Q000628:therapy; D010392:Pemphigus / Q000276:immunology / Q000473:pathology / Q000628:therapy; D012872:Skin Diseases, Vesiculobullous / Q000276:immunology* / Q000473:pathology / Q000628:therapy
chemical_list: D001323:Autoantibodies; D007070:Immunoglobulin A